Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medipal Holdings's Accounts Payable for the quarter that ended in Mar. 2026 was 円984,534 Mil.
Medipal Holdings's quarterly Accounts Payable
increased
from Sep. 2025 (円1,002,231 Mil) to Dec. 2025 (円1,106,263 Mil) but then
declined
from Dec. 2025 (円1,106,263 Mil) to Mar. 2026 (円984,534 Mil).
Medipal Holdings's annual Accounts Payable
increased
from Mar. 2024 (円924,297 Mil) to Mar. 2025 (円932,474 Mil) and
increased
from Mar. 2025 (円932,474 Mil) to Mar. 2026 (円984,534 Mil).
Medipal Holdings Accounts Payable Related Terms
Medipal Holdings Accounts Payable Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Accounts Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
What does a Accounts Payable of 円984,534 Mil mean?
Medipal Holdings (TSE:7459) has a Accounts Payable of 円984,534 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' Accounts Payable too high?
Medipal Holdings' current Accounts Payable is 円984,534 Mil. Overall, Medipal Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Accounts Payable compare to MCK and CAH?
Medipal Holdings' Accounts Payable of 円984,534 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Distribution company?
A good Accounts Payable depends on the Medical Distribution industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current Accounts Payable is 円984,534 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,734.57, compared to a current price of 円2,854.00 — trading 4.4% above its estimated fair value. The current Accounts Payable is 円984,534 Mil. Medipal Holdings' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current Accounts Payable is 円984,534 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (TSE:7459) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of 円2,854.00 is trading 4.4% above its estimated GF Value™ of 円2,734.57.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for TSE:7459:
Accounts Payable: 円984,534 Mil
GF Value™: 円2,734.57 vs. price of 円2,854.00 (4.4% above fair value)
No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
82GF Score
Get the complete analysis for TSE:7459
Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7459 has been successfully added to your 
